Up-regulation of TRAF2 inhibits chondrocytes apoptosis in lumbar facet joint osteoarthritis

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1659-1665. doi: 10.1016/j.bbrc.2018.07.096. Epub 2018 Jul 25.

Abstract

Tumor necrosis factor receptor-associated factor 2 (TRAF2) has been demonstrated that it plays a significant role in cell death receptor signal transduction. The purpose of this study was to investigate the expression of TRAF2 and its possible role in FJOA. We observed an up-regulation of TRAF2 in FJOA by immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) compared to normal tissues. In vitro, we used TNF-α to stimulate Human SW1353 chondrosarcoma cells to establish the chondrocytes injury model. Western blot analysis revealed significant expression of TRAF2 and cleaved caspase-3/8 in SW1353 cells. Co-localization of TRAF2/cleaved caspase-3/8 was detected in the cells injury model by double-labeling immunofluorescent staining. We demonstrated a possible anti-apoptotic effect of TRAF2 in chondrocyte apoptosis in FJOA by knockdown of its expression with siRNA. Moreover, TRAF2 knockdown was demonstrated to enhance TNF-α-induced apoptosis by flow cytometry assay. In conclusion, our results show that the up-regulation of TRAF2 may play an important role in the inhibition of chondrocyte apoptosis of FJOA.

Keywords: Apoptosis; Lumbar facet joint; Osteoarthritis; TRAF2; Tumor necrosis factor-alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Chondrocytes / metabolism*
  • Chondrocytes / pathology*
  • Humans
  • Middle Aged
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • Osteoarthritis / physiopathology*
  • TNF Receptor-Associated Factor 2 / metabolism*
  • Up-Regulation*
  • Zygapophyseal Joint / metabolism*
  • Zygapophyseal Joint / pathology

Substances

  • PSMD2 protein, human
  • TNF Receptor-Associated Factor 2